Format

Send to

Choose Destination
Cancer Radiother. 2015 Oct;19(6-7):573-81. doi: 10.1016/j.canrad.2015.05.020. Epub 2015 Sep 2.

[Follow-up after stereotactic body radiation therapy for liver tumours: A review of the literature and recommendations].

[Article in French]

Author information

1
Clinique d'oncologie radiothérapie, centre Henry-S.-Kaplan, CHRU de Tours, 2, boulevard Tonnellé, 37044, Tours, France. Electronic address: guillaume.janoray@yahoo.fr.
2
Département de radiothérapie oncologie, centre hospitalier Lyon-Sud, 165, chemin du Grand-Revoyet, 69310 Pierre-Bénite, France; EMR 3738, université Claude-Bernard Lyon 1, 69373 Lyon cedex 08, France.

Abstract

Stereotactic body radiation therapy is a modern approach for delivering ablative high doses of irradiation in small volumes. This technique is being developed for the treatment of liver tumors, such as hepatocellular carcinoma, cholangiocarcinoma, or liver metastases. It represents a real alternative to surgical resection or liver transplantation when patients are inoperable or when tumours are unresectable. It is mandatory to standardize and simplify the current methods of evaluation and monitoring in order to benefit from a better understanding of the effectiveness and of the tolerance of this new treatment modality. Several scientific societies have recently proposed recommendations for the implementation of stereotactic radiotherapy for liver tumors. We conducted a literature review to provide recommendations for follow-up after completion of a stereotactic body radiation therapy for liver tumours.

KEYWORDS:

Carcinome hépatocellulaire; Cholangiocarcinoma; Cholangiocarcinome; Follow-up; Hepatocellular carcinoma; Liver SBRT; Liver metastases; Métastases hépatiques; Radiothérapie stéréotaxique; Stereotactic radiation body therapy; Suivi

PMID:
26341312
DOI:
10.1016/j.canrad.2015.05.020
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center